Stock listing

NASDAQ:BIAF bioAffinity Technologies, Inc. Stock

Home listing (NASDAQ) of bioAffinity Technologies, Inc.

Follow bioAffinity Technologies, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BIAF

$2.91 USD -0.12 (-4.0%)

Close on Oct 30, 2026

Past year -92.0% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$2.86 – $3.04 USDOct 30, 2026
Volume
46,406 sharesOct 30, 2026
Market cap
$3.73M USDAt the close on Oct 30, 2026 · price × 1.28M shares outstanding
52-week range
$2.66 – $80.70 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$30.71M USDMedian day 122,658 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
bioAffinity Technologies, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BIAF · Home$2.91 USD-0.12 (-4.0%)46,406$3.04$3.04$2.861$3.03Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:BIAF · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.91-0.12-4.0%$3.04$3.04$2.86146,406
$3.03-0.11-3.5%$3.02$3.29$2.99325,549
$3.14+0.18+6.1%$2.914$3.16$2.8454,729
$2.96+0.13+4.6%$2.81$3.14$2.75188,570
$2.83+0.03+1.1%$2.80$2.88$2.6670,426
$2.80-0.37-11.7%$3.17$3.265$2.80124,590
$3.17-0.40-11.2%$3.50$3.73$3.1490,624
$3.57-0.09-2.5%$3.68$3.69$3.5464,795
$3.66+0.15+4.3%$3.44$3.75$3.4489,086
$3.51-0.22-5.9%$3.67$3.69$3.4372,982
$3.73-0.23-5.8%$3.95$3.95$3.60101,847
$3.96+0.40+11.2%$3.47$4.10$3.406278,093
$3.56-0.065-1.8%$3.42$3.68$3.411120,725
$3.625-0.275-7.1%$3.52$3.74$3.23892,274
$3.90-0.825-17.5%$4.75$4.75$3.76284,992
$4.725-0.915-16.2%$5.41$5.48$4.68657,427
$5.64-0.52-8.4%$6.35$9.38$5.5035,253,385
$6.16+0.10+1.7%$5.90$6.28$5.8687,687
$6.06-0.13-2.1%$6.56$6.598$5.90259,250
$6.19+0.135+2.2%$5.93$6.20$5.85106,502
$6.055-0.09-1.5%$6.06$6.235$5.90154,642
$6.145-0.415-6.3%$6.56$6.865$6.07247,549
$6.56-0.32-4.7%$6.56$7.00$6.56108,540
$6.88-0.53-7.2%$7.31$7.34$6.66150,294
$7.41-0.52-6.6%$7.74$8.00$7.27481,316
$7.93+0.10+1.3%$7.815$7.96$7.67129,343
$7.83-0.11-1.4%$7.67$8.00$7.50220,567
$7.94-0.615-7.2%$8.40$8.55$7.82207,877
$8.555+0.855+11.1%$8.28$9.14$8.26874,297
$7.70-1.73-18.3%$8.39$8.80$7.371757,221
$9.43+0.68+7.8%$10.66$12.48$9.2310,309,394
$8.75+3.40+63.6%$7.00$11.00$6.4525,410,034
$5.35-1.01-15.9%$6.01$6.31$5.11279,118
$6.36-1.57-19.8%$7.14$7.317$6.03363,062
$7.93-0.02-0.3%$7.71$8.23$7.50366,869
$7.95-1.44-15.3%$9.96$10.08$7.82827,861
$9.39-1.11-10.6%$9.53$10.49$9.38793,879
$10.50+1.57+17.6%$10.90$12.32$10.0910,455,635
$8.93-6.34-41.5%$10.63$10.63$8.362,411,951
$15.27+2.49+19.5%$11.12$20.35$10.9020,085,150
$12.78+3.03+31.1%$13.20$13.58$11.0619,253,783
$9.75+3.16+48.0%$7.61$11.75$7.5446,047,680
$6.59+2.03+44.5%$7.72$8.60$6.1346,392,727
$4.56-0.31-6.4%$4.83$4.98$4.5636,149
$4.87-0.19-3.8%$4.95$5.17$4.8730,377
$5.06-0.03-0.6%$5.00$5.13$4.9643,404
$5.09-0.10-1.9%$5.19$5.32$4.8879,678
$5.19-0.63-10.8%$5.40$5.47$5.0888,772
$5.82-0.18-3.0%$6.02$6.35$5.725167,437
$6.00-0.0020.0%$5.76$6.297$5.4774,563
$6.002-0.133-2.2%$5.793$6.674$5.47515,071
$6.135-0.965-13.6%$6.771$6.771$5.86819,098
$7.10+1.22+20.7%$7.982$8.547$6.525756,209
$5.88-0.152-2.5%$6.225$6.30$5.7751,515
$6.032+0.287+5.0%$5.85$6.206$5.7832,258
$5.745-1.346-19.0%$6.795$6.90$4.8783,746
$7.091-0.199-2.7%$7.35$7.35$7.05250
$7.29-0.06-0.8%$7.412$7.497$6.86901
$7.35-0.30-3.9%$7.50$7.80$7.352,363
$7.65-0.295-3.7%$7.95$7.958$7.6052,347
$7.945-0.0020.0%$7.92$7.95$7.697963
$7.947-0.309-3.7%$8.40$8.847$7.6951,265
$8.256-0.705-7.9%$8.85$9.068$8.251,360
$8.961-0.45-4.8%$9.135$9.30$8.702791
$9.411-0.255-2.6%$9.60$9.60$8.788504
$9.666+0.891+10.2%$8.775$9.842$8.402800
Ticker
NASDAQ:BIAF
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Bioaffinity Technologies (NASDAQ:BIAF) Q4 2022 Earnings Call

    Mon, Apr 03, 2023 · 9:00 AM ET

    Watch Transcript

  • Bioaffinity Technologies (NASDAQ:BIAF) Q3 2022 Earnings Call

    Mon, Nov 14, 2022 · 8:00 AM ET

    Watch Transcript

Latest news

bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month

Oct 29, 2026

Closed $3.03 (-3.5%) on Oct 29, 2026

bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026

Oct 15, 2026

Closed $3.96 (+11.2%) on Oct 15, 2026

bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026

Oct 13, 2026

Closed $3.63 (-7.1%) on Oct 13, 2026

BioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Oct 9, 2026

Closed $4.73 (-16.2%) on Oct 9, 2026

bioAffinity Technologies Announces Notification of Japanese Patent Allowance Covering Noninvasive CyPath® Lung and AI-Built Algorithm

Oct 8, 2026

Closed $5.64 (-8.4%) on Oct 8, 2026

bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026

Oct 6, 2026

Closed $6.06 (-2.1%) on Oct 6, 2026

BioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL

Sep 30, 2026

Closed $6.56 (-4.7%) on Sep 30, 2026

BioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference

Sep 22, 2026

Closed $8.56 (+11.1%) on Sep 22, 2026

BioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath(R) Lung Noninvasive Lung Cancer Diagnostic

Sep 18, 2026

Closed $9.43 (+7.8%) on Sep 18, 2026

BioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic

Sep 17, 2026

Closed $8.75 (+63.6%) on Sep 17, 2026

All bioAffinity Technologies, Inc. news

Financings

  • Registered direct offering of common stock (or pre-funded warrants in lieu thereof)

    Oct 9, 2026

    Closed: US$4M raised · US$6.122 a share · WallachBeth Capital, LLC

    Dealers: WallachBeth Capital, LLC (lead)

    Buyers: institutional investor

    Use of proceeds: Working capital, supporting expected growing sales for CyPath Lung, and general corporate purposes

    Announced Oct 8, 2026 · Closed Oct 9, 2026

  • Private placement of warrants to purchase common stock

    Oct 9, 2026

    Closed: Warrants at US$6.122 for 60 months

    Announced Oct 8, 2026 · Closed Oct 9, 2026

  • Private placement of pre-funded warrants with accompanying warrants

    Aug 17, 2026

    Closed: US$4M raised · US$0.4657 a share · Warrants at US$0.4727 for 60 months · WallachBeth Capital LLC

    Dealers: WallachBeth Capital LLC (lead)

    Announced Aug 13, 2026 · Closed Aug 17, 2026

Read by 6ix AI from the company's releases

Decks

bioAffinity Technologies, Inc. on 6ix

News releases
51 in the last 12 months · 133 in all · newest Oct 29, 2026 · oldest 2022
Calls
2 calls with a replay · 2 with a transcript · latest Apr 3, 2023
Decks
6 decks · latest Sep 11, 2026

Where bioAffinity Technologies, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BIAF · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BIAFBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about bioAffinity Technologies, Inc.